| Year |
Citation |
Score |
| 2019 |
Augert A, Eastwood E, Ibrahim AH, Wu N, Grunblatt E, Basom R, Liggitt D, Eaton KD, Martins R, Poirier JT, Rudin CM, Milletti F, Cheng WY, Mack F, MacPherson D. Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition. Science Signaling. 12. PMID 30723171 DOI: 10.1126/Scisignal.Aau2922 |
0.324 |
|
| 2017 |
Brouwer-Visser J, Cheng WY, Bauer-Mehren A, Maisel D, Lechner K, Andersson E, Dudley JT, Milletti F. Regulatory T-cell genes drive altered immune microenvironment in adult solid cancers and allow for immune contextual patient subtyping. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29133367 DOI: 10.1158/1055-9965.EPI-17-0461 |
0.317 |
|
| 2014 |
Ou Yang TH, Cheng WY, Zheng T, Maurer MA, Anastassiou D. Breast cancer prognostic biomarker using attractor metagenes and the FGD3-SUSD3 metagene. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2850-6. PMID 25249324 DOI: 10.1158/1055-9965.Epi-14-0399 |
0.662 |
|
| 2014 |
Miller CP, Thorpe JD, Kortum AN, Coy CM, Cheng WY, Ou Yang TH, Anastassiou D, Beatty JD, Urban ND, Blau CA. JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors. Cancer Immunology Research. 2: 301-6. PMID 24764577 DOI: 10.1158/2326-6066.Cir-13-0189 |
0.582 |
|
| 2014 |
Cheng W, Yang TO, Maurer M, Anastassiou D. Abstract 2878: BCAM (breast cancer attractor metagenes): A new tool for assessing breast cancer prognosis Cancer Research. 74: 2878-2878. DOI: 10.1158/1538-7445.Am2014-2878 |
0.671 |
|
| 2013 |
Hernandez SL, Banerjee D, Garcia A, Kangsamaksin T, Cheng WY, Anastassiou D, Funahashi Y, Kadenhe-Chiweshe A, Shawber CJ, Kitajewski JK, Kandel JJ, Yamashiro DJ. Notch and VEGF pathways play distinct but complementary roles in tumor angiogenesis. Vascular Cell. 5: 17. PMID 24066611 DOI: 10.1186/2045-824X-5-17 |
0.525 |
|
| 2013 |
Cheng WY, Ou Yang TH, Anastassiou D. Development of a prognostic model for breast cancer survival in an open challenge environment. Science Translational Medicine. 5: 181ra50. PMID 23596202 DOI: 10.1126/Scitranslmed.3005974 |
0.68 |
|
| 2013 |
Cheng WY, Ou Yang TH, Anastassiou D. Biomolecular events in cancer revealed by attractor metagenes. Plos Computational Biology. 9: e1002920. PMID 23468608 DOI: 10.1371/journal.pcbi.1002920 |
0.672 |
|
| 2012 |
Cheng WY, Kandel JJ, Yamashiro DJ, Canoll P, Anastassiou D. A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. Plos One. 7: e34705. PMID 22493711 DOI: 10.1371/Journal.Pone.0034705 |
0.694 |
|
| 2012 |
Cheng W, Anastassiou D. A subset of co-expressed genes in Slug-based cancer mesenchymal transition signature remains coexpressed in normal samples in a tissue-specific manner Nature Precedings. 7: 1-1. DOI: 10.1038/Npre.2012.6813.1 |
0.692 |
|
| 2011 |
Anastassiou D, Rumjantseva V, Cheng W, Huang J, Canoll PD, Yamashiro DJ, Kandel JJ. Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo. Bmc Cancer. 11: 529. PMID 22208948 DOI: 10.1186/1471-2407-11-529 |
0.695 |
|
| 2011 |
Cheng W, Kandel JJ, Yamashiro DJ, Canoll P, Anastassiou D. Slug-based epithelial-mesenchymal transition gene signature is associated with prolonged time to recurrence in glioblastoma Nature Precedings. DOI: 10.1038/Npre.2011.6544.1 |
0.616 |
|
| 2011 |
Anastassiou D, Rumjantseva V, Cheng W, Huang J, Canoll PD, Yamashiro DJ, Kandel JJ. Human Cancer Cells Express Slug-based Epithelial-Mesenchymal Transition Gene Signature Obtained in Vivo Nature Precedings. DOI: 10.1038/Npre.2011.6243.1 |
0.692 |
|
| 2011 |
Cheng W, Kim H, Kandel J, Anastassiou D. Cancer invasion associated gene expression signature is present in differentially expressed genes in the reprogramming of fibroblasts into stem cells Nature Precedings. DOI: 10.1038/Npre.2011.5924.1 |
0.683 |
|
| Show low-probability matches. |